Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU.
Over the past 50 years, medicines have made a huge contribution to improving the health status of populations. However, the level of pharmaceutical innovation varies widely, ranging from breakthrough treatments for life-threatening diseases to minor modifications of medicines that have been on the market for some time. Once innovative medicines approach the market, a system of measuring the level of innovation should be established. This perspective describes the current situation, the challenges and initiatives, and formulates recommendations for a coordinated EU action to measure the level of pharmaceutical innovation. In our opinion, comparative effectiveness research needs to play a central role in measuring the level of pharmaceutical innovation.
Belgian Health Care Knowledge Centre, Administratief Centrum Kruidtuin, Door Building, Kruidtuinlaan 55, 1000 Brussel, Belgium.
Lieven
L
Annemans
Irina
I
Cleemput
Frank
F
Hulstaert
Steven
S
Simoens
D057186:Comparative Effectiveness Research; D055808:Drug Discovery / Q000592:standards*; D004345:Drug Industry; D005062:European Union; D006801:Humans